- Ogrodnik M, Salmonowicz H, Gladyshev VN. Integrating cellular senescence with the concept of damage accumulation in aging: Relevance for clearance of senescent cells. Aging cell. 2019;18(1):e12841.
- Foreman J. Exercise is Medicine: How Physical Activity Boosts Health and Slows Aging: Oxford University Press; 2019.
- Sommerlad A, Perera G, Singh-Manoux A, Lewis G, Stewart R, Livingston G. Accuracy of general hospital dementia diagnoses in England: sensitivity, specificity, and predictors of diagnostic accuracy 2008–2016. Alzheimer's & Dementia. 2018;14(7):933-43.
- Anand R, Gill KD, Mahdi AA. Therapeutics of Alzheimer's disease: Past, present and future. Neuropharmacology. 2014;76:27-50.
- Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nature reviews Disease primers. 2021;7(1):33.
- Hajibabaie F, Abedpoor N, Taghian F, Safavi K. A cocktail of polyherbal bioactive compounds and regular mobility training as senolytic approaches in age-dependent alzheimer’s: the in silico analysis, lifestyle intervention in old age. Journal of Molecular Neuroscience. 2023;73(2-3):171-84.
- Liang Y-J, Su Q-W, Sheng Z-R, Weng Q-Y, Niu Y-F, Zhou H-D, et al. Effectiveness of physical activity interventions on cognition, neuropsychiatric symptoms, and quality of life of Alzheimer’s disease: An update of a systematic review and meta-analysis. Frontiers in aging neuroscience. 2022;14:155.
- Kivimäki M, Singh-Manoux A, Pentti J, Sabia S, Nyberg ST, Alfredsson L, et al. Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis. bmj. 2019;365.
- Lubitz I, Ricny J, Atrakchi‐Baranes D, Shemesh C, Kravitz E, Liraz‐Zaltsman S, et al. High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model. Aging Cell. 2016;15(2):309-16.
- Delagarza VW. Pharmacologic treatment of Alzheimer's disease: an update. American Family Physician. 2003;68(7):1365-73.
- Sabogal-Guáqueta AM, Osorio E, Cardona-Gómez GP. Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer's mice. Neuropharmacology. 2016;102:111-20.
- Hajibabaie F, Abedpoor N, Javanmard SH, Hasan A, Sharifi M, Rahimmanesh I, et al. The molecular perspective on the development of melanoma and genome engineering of T-cells in targeting therapy. Environmental Research. 2023:116980.
- Li W-y, Gao J-y, Lin S-Y, Pan S-t, Xiao B, Ma Y-t, et al. Effects of involuntary and voluntary exercise in combination with Acousto-optic stimulation on adult neurogenesis in an Alzheimer's mouse model. Molecular Neurobiology. 2022;59(5):3254-79.
- Xiang S, Liu F, Lin J, Chen H, Huang C, Chen L, et al. Fucoxanthin inhibits β-amyloid assembly and attenuates β-amyloid oligomer-induced cognitive impairments. Journal of agricultural and food chemistry. 2017;65(20):4092-102.
- Abedpoor N, Taghian F, Ghaedi K, Niktab I, Safaeinejad Z, Rabiee F, et al. PPARγ/Pgc-1α-Fndc5 pathway up-regulation in gastrocnemius and heart muscle of exercised, branched chain amino acid diet fed mice. Nutrition & metabolism. 2018;15(1):1-15.
- Santos ECd, Silva LS, Pinheiro AS, Teixeira DE, Peruchetti DB, Silva-Aguiar RP, et al. The monoterpene 1, 8-cineole prevents cerebral edema in a murine model of severe malaria. Plos one. 2022;17(5):e0268347.
- Liu S, Fan M, Zheng Q, Hao S, Yang L, Xia Q, et al. MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets. Biomedicine & Pharmacotherapy. 2022;148:112681.
- Ren Z, Yu J, Wu Z, Si W, Li X, Liu Y, et al. MicroRNA-210-5p contributes to cognitive impairment in early vascular dementia rat model through targeting Snap25. Frontiers in Molecular Neuroscience. 2018;11:388.
- Nunomura A, Perry G. RNA and oxidative stress in Alzheimer’s disease: focus on microRNAs. Oxidative medicine and cellular longevity. 2020;2020.
- Ramakrishna S, Muddashetty RS. Emerging role of microRNAs in dementia. Journal of molecular biology. 2019;431(9):1743-62.
- Smith PY, Hernandez-Rapp J, Jolivette F, Lecours C, Bisht K, Goupil C, et al. miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Human molecular genetics. 2015;24(23):6721-35.
- Li Y, Zhang T, Zhou Y, Sun Y, Cao Y, Chang X, et al. A Presenilin/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis. Scientific reports. 2016;6(1):36136.
- Hajibabaie F, Kouhpayeh S, Mirian M, Rahimmanesh I, Boshtam M, Sadeghian L, et al. MicroRNAs as the actors in the atherosclerosis scenario. Journal of physiology and biochemistry. 2020;76:1-12.
- Hajibabaie F, Abedpoor N, Assareh N, Tabatabaiefar MA, Shariati L, Zarrabi A. The importance of SNPs at miRNA binding sites as biomarkers of gastric and colorectal cancers: a systematic review. Journal of Personalized Medicine. 2022;12(3):456.
- Watts M, Williams G, Lu J, Nithianantharajah J, Claudianos C. MicroRNA-210 Knockout Alters Dendritic Density and Behavioural Flexibility. bioRxiv. 2019:762450.
- Siedlecki-Wullich D, Català-Solsona J, Fábregas C, Hernández I, Clarimon J, Lleó A, et al. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease. Alzheimer's research & therapy. 2019;11:1-11.
- Khan A, Vaibhav K, Javed H, Tabassum R, Ahmed ME, Khan MM, et al. 1, 8-cineole (eucalyptol) mitigates inflammation in amyloid Beta toxicated PC12 cells: relevance to Alzheimer’s disease. Neurochemical research. 2014;39:344-52.
|